Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer

scientific article published on August 2017

Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1090936411
P356DOI10.1245/S10434-017-5941-0
P698PubMed publication ID28766212

P50authorCarla S. FisherQ87139983
Brian CzernieckiQ88334128
P2093author name stringJulia Tchou
Paul J Zhang
Lucy M De La Cruz
Kahyun Yoon-Flannery
Joey Bahng
Lauren M DeStefano
Rose E Mustafa
P2860cites workProgression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysisQ33243821
Early dissemination seeds metastasis in breast cancerQ33562263
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancerQ36955125
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancerQ37270033
Expression of HER2neu in ductal carcinoma in situ is associated with local recurrenceQ37940691
Breast cancer statistics, 2015: Convergence of incidence rates between black and white womenQ40379855
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In SituQ41467413
HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component.Q42480187
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.Q50592584
P577publication date2017-08-01
P1433published inAnnals of Surgical OncologyQ2853069
P1476titleEvaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer

Reverse relations

cites work (P2860)
Q90275893A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast
Q90593569In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ
Q95857000Predictors for upstaging of ductal carcinoma in situ (DCIS) to invasive carcinoma in non-mass-type DCIS
Q90394997Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile

Search more.